Hims & Hers Health Posts Mixed Q1 Amid Weight-Loss Product ‘Noise’: Analysts

All NewsMay 12, 2026

Hims & Hers Health shares tank after disappointing Q1 results. Company raised 2026 revenue outlook. EBITDA outlook was lowered by $25M.

Latest Ratings for HIMS

DateFirmActionFromTo Mar 2022Deutsche BankInitiates Coverage OnHold Dec 2021CitigroupMaintainsBuy Dec 2021JefferiesInitiates Coverage OnHold

View More Analyst Ratings for HIMS

View the Latest Analyst Ratings

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT